SEC Company Response from POMDOCTOR Ltd (POM) (CIK 0001877971) (POM) — Sep 26, 2025
POMDOCTOR Ltd (POM) (CIK 0001877971)
Date: Sept. 26, 2025 · CIK: 0001877971 · Accession: 0001213900-25-092306
AI Filing Summary & Sentiment
File numbers found in text: 333-285771
Show Raw Text
CORRESP
1
filename1.htm
Joseph Stone Capital, LLC
585 Stewart Avenue, Suite L-60C
Garden City, New York 11501
1 (866) 866-1433
September 26, 2025
VIA EDGAR
U.S. Securities & Exchange Commission
Division of Corporation Finance
Office of Trade & Services
100 F Street, NE
Washington, D.C. 20549
Attn:
Patrick Kuhn
Joel Parker
Scott Anderegg
Dietrich King
Re:
POMDOCTOR LIMITED
Registration Statement on Form F-1
Initially filed on March 13, 2025, as amended
File No. 333-285771
Ladies and Gentlemen:
Pursuant to Rule 461 under
the Securities Act of 1933, as amended (the “Securities Act”), Joseph Stone Capital, LLC, as representative of the several
Underwriters of the offering hereby joins in the request of POMDOCTOR LIMITED to request acceleration of effectiveness of the above referenced
Registration Statement on Form F-1 so that it will become effective on September 30, 2025, at 4:00 p.m. Eastern Time, or as soon thereafter
as practicable.
The undersigned has complied
and will comply, and has been informed or will be informed by any participating dealers that they have complied or will comply, with the
requirements of Rule 15e2-8 under the Securities and Exchange Act of 1934, as amended.
Very truly yours,
By:
/s/ Damian Maggio
Name:
Damian Maggio
Title:
Chief Executive Officer
cc:
Ellenoff Grossman & Schole LLP